Literature DB >> 19655208

Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy.

Toshiyasu Ojima1, Makoto Iwahashi, Mikihito Nakamori, Masaki Nakamura, Teiji Naka, Masahiro Katsuda, Takeshi Iida, Keiji Hayata, Hiroki Yamaue.   

Abstract

INTRODUCTION: The relationship between perioperative allogeneic blood transfusions and poor prognosis in patients with gastric cancer remains controversial. The aim of this study is to examine the effect of perioperative blood transfusions on long-term survival of patients undergoing curative gastric resection for gastric cancer.
METHODS: Eight hundred fifty-six consecutive patients with gastric cancer who underwent curative gastrectomy (R0) from January 1, 1991 through December 31, 2002 were enrolled in this retrospective study.
RESULTS: A multivariate overall survival analysis using Cox proportional hazard regression model revealed macroscopically infiltrative tumor, tumor infiltration of serosa, lymph node metastasis, blood transfusions (hazard ratio, 2.69), pulmonary disease, and liver dysfunction as prognostic factors for long-term survival. Blood transfusion was an independent prognostic factor at all stages of disease. Disease-specific and overall survival showed significant differences between the transfused and nontransfused groups (log-rank, P < 0.0001). Based on multivariate logistic regression analysis, the need for blood transfusion was significantly associated with advanced age (>or=65 years), long duration of operation (>or=300 min), massive blood loss (>or=1,000 ml), and anemia (Hb < 10 g/dl).
CONCLUSIONS: Allogeneic blood transfusion is an independent prognostic factor for long-term survival in gastric cancer patients.

Entities:  

Mesh:

Year:  2009        PMID: 19655208     DOI: 10.1007/s11605-009-0973-9

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  38 in total

1.  Search for immunomodulatory effects of blood transfusion in gastric cancer patients: flow cytometry of Th1/Th2 cells in peripheral blood.

Authors:  C F Sun; Y Y Hsieh; K W Ngan; W T Wang
Journal:  Ann Clin Lab Sci       Date:  2001-04       Impact factor: 1.256

2.  Lack of relationship between perioperative blood transfusion and survival time after curative resection for gastric cancer.

Authors:  S Moriguchi; Y Maehara; K Akazawa; K Sugimachi; Y Nose
Journal:  Cancer       Date:  1990-12-01       Impact factor: 6.860

Review 3.  Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD.

Authors:  François Durand; Dominique Valla
Journal:  J Hepatol       Date:  2004-12-24       Impact factor: 25.083

4.  Prognostic significance of bone marrow micrometastases in patients with gastric cancer.

Authors:  K W Jauch; M M Heiss; U Gruetzner; I Funke; K Pantel; R Babic; H J Eissner; G Riethmueller; F W Schildberg
Journal:  J Clin Oncol       Date:  1996-06       Impact factor: 44.544

5.  Blood transfusion and other risk factors for recurrence of cancer of the head and neck.

Authors:  K R Jones; M C Weissler
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1990-03

6.  A tailored perioperative blood transfusion might avoid undue recurrences in gastric carcinoma patients.

Authors:  D K Dhar; H Kubota; M Tachibana; T Kotoh; S Kinugasa; M Shibakita; H Kohno; N Nagasue
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

7.  Influence of overweight on patients with gastric cancer after undergoing curative gastrectomy: an analysis of 689 consecutive cases managed by a single center.

Authors:  Toshiyasu Ojima; Makoto Iwahashi; Mikihito Nakamori; Masaki Nakamura; Teiji Naka; Koichiro Ishida; Kentaro Ueda; Masahiro Katsuda; Takeshi Iida; Toshiaki Tsuji; Hiroki Yamaue
Journal:  Arch Surg       Date:  2009-04

8.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

9.  Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases.

Authors:  David A Kooby; Jennifer Stockman; Leah Ben-Porat; Mithat Gonen; William R Jarnagin; Ronald P Dematteo; Scott Tuorto; David Wuest; Leslie H Blumgart; Yuman Fong
Journal:  Ann Surg       Date:  2003-06       Impact factor: 12.969

10.  Perioperative blood transfusion has prognostic significance for breast cancer.

Authors:  P I Tartter; L Burrows; A E Papatestas; G Lesnick; A H Aufses
Journal:  Surgery       Date:  1985-02       Impact factor: 3.982

View more
  30 in total

1.  The impact of abdominal shape index of patients on laparoscopy-assisted distal gastrectomy for early gastric cancer.

Authors:  Toshiyasu Ojima; Makoto Iwahashi; Mikihito Nakamori; Masaki Nakamura; Katsunari Takifuji; Masahiro Katsuda; Takeshi Iida; Toshiaki Tsuji; Keiji Hayata; Hiroki Yamaue
Journal:  Langenbecks Arch Surg       Date:  2011-12-02       Impact factor: 3.445

2.  The evaluation of surgical treatment for gastric cancer patients with noncurative resection.

Authors:  Teiji Naka; Makoto Iwahashi; Mikihito Nakamori; Masaki Nakamura; Toshiyasu Ojima; Takeshi Iida; Masahiro Katsuda; Tsuji Toshiaki; Hayata Keiji; Hiroki Yamaue
Journal:  Langenbecks Arch Surg       Date:  2012-08       Impact factor: 3.445

3.  Impact of intraoperative blood loss on survival after curative resection for gastric cancer.

Authors:  Yue-Xiang Liang; Han-Han Guo; Jing-Yu Deng; Bao-Gui Wang; Xue-Wei Ding; Xiao-Na Wang; Li Zhang; Han Liang
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

4.  Oncologic outcomes of laparoscopy-assisted gastrectomy for advanced gastric cancer: a large-scale multicenter retrospective cohort study from China.

Authors:  Yanfeng Hu; Mingang Ying; Changming Huang; Hongbo Wei; Zhiwei Jiang; Xiang Peng; Jiankun Hu; Xiaohui Du; Baolin Wang; Feng Lin; Jian Xu; Guanglong Dong; Tingyu Mou; Guoxin Li
Journal:  Surg Endosc       Date:  2014-03-21       Impact factor: 4.584

5.  Adverse prognostic impact of perioperative allogeneic transfusion on patients with stage II/III gastric cancer.

Authors:  Mitsuro Kanda; Daisuke Kobayashi; Chie Tanaka; Naoki Iwata; Suguru Yamada; Tsutomu Fujii; Goro Nakayama; Hiroyuki Sugimoto; Masahiko Koike; Shuji Nomoto; Kenta Murotani; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  Gastric Cancer       Date:  2015-01-07       Impact factor: 7.370

6.  The effect of intra- and postoperative allogenic blood transfusion on patients' survival undergoing radical cystectomy for urothelial carcinoma of the bladder.

Authors:  M Gierth; A Aziz; H M Fritsche; M Burger; W Otto; F Zeman; M T Pawlik; E Hansen; M May; S Denzinger
Journal:  World J Urol       Date:  2014-02-08       Impact factor: 4.226

7.  Prognostic Impact of Splenectomy in Patients with Esophagogastric Junction Carcinoma.

Authors:  Minoru Fukuchi; Erito Mochiki; Toru Ishiguro; Kana Saito; Hiroshi Naitoh; Youichi Kumagai; Keiichiro Ishibashi; Hideyuki Ishida
Journal:  In Vivo       Date:  2018 Jan-Feb       Impact factor: 2.155

8.  The impact of blood transfusion on perioperative outcomes following gastric cancer resection: an analysis of the American College of Surgeons National Surgical Quality Improvement Program database.

Authors:  Maryam Elmi; Alyson Mahar; Daniel Kagedan; Calvin H L Law; Paul J Karanicolas; Yulia Lin; Jeannie Callum; Natalie G Coburn; Julie Hallet
Journal:  Can J Surg       Date:  2016-09       Impact factor: 2.089

9.  Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome.

Authors:  Terence C Chua; Winston Liauw; David L Morris
Journal:  Int J Colorectal Dis       Date:  2011-08-19       Impact factor: 2.571

10.  The impact of peri-operative blood transfusions on post-pancreatectomy short-term outcomes: an analysis from the American College of Surgeons National Surgical Quality Improvement Program.

Authors:  Julie Hallet; Alyson L Mahar; Melanie E Tsang; Yulia Lin; Jeannie Callum; Natalie G Coburn; Calvin H L Law; Paul J Karanicolas
Journal:  HPB (Oxford)       Date:  2015-08-24       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.